Hikal Ltd
NSE:HIKAL

Watchlist Manager
Hikal Ltd Logo
Hikal Ltd
NSE:HIKAL
Watchlist
Price: 391.05 INR 1.12% Market Closed
Market Cap: 48.2B INR
Have any thoughts about
Hikal Ltd?
Write Note

Hikal Ltd
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hikal Ltd
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Hikal Ltd
NSE:HIKAL
Total Liabilities
â‚ą13B
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Liabilities
â‚ą106.1B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Liabilities
â‚ą62.9B
CAGR 3-Years
-3%
CAGR 5-Years
-6%
CAGR 10-Years
4%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Liabilities
â‚ą190B
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Liabilities
â‚ą75.8B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
5%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Liabilities
â‚ą26B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hikal Ltd
Glance View

Market Cap
48.2B INR
Industry
Pharmaceuticals

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. The company is headquartered in Navi Mumbai, Maharashtra. The Company’s operating segments include the crop protection and pharmaceuticals space. The Crop protection produce and trades in pesticides and herbicides. Its facilities are in Taloja, Mahad (Maharashtra), and Panoli (Gujarat). The Pharmaceuticals space produce and trades in active pharmaceuticals ingredients. Its facilities are in Jigani (Bengaluru) and Panoli (Gujarat). The Company’s products and services include gabapentin, thiabendazole, and diuron contract development and custom manufacturing of intermediates, application programming interface (APIs), and artificial intelligence (AI’s). The company offers solutions to route scouting, process development, analytical method development, technology development, process engineering, scale-up support, and small-scale synthesis.

HIKAL Intrinsic Value
264.85 INR
Overvaluation 32%
Intrinsic Value
Price

See Also

What is Hikal Ltd's Total Liabilities?
Total Liabilities
13B INR

Based on the financial report for Jun 30, 2024, Hikal Ltd's Total Liabilities amounts to 13B INR.

What is Hikal Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 3Y
10%

Over the last year, the Total Liabilities growth was 4%. The average annual Total Liabilities growth rates for Hikal Ltd have been 10% over the past three years .

Back to Top